Clinical Chemistry Analyzers & Reagents

Publication Date	October 2008
Publisher	Global Industry Analysts
Product Type	Report
Pages	365
ISBN Number	not applicable
Product Code	GIA00938

Buy this product or for assistance call +44 20 7060 7474

PDF £2,375.00$3951 | €2658

FAX Order above formats by FAX

Summary

This report analyzes the worldwide markets for Clinical Chemistry Analyzers in Millions of US$. The major product segments analyzed are Analyzers (Large Volume Clinical Chemistry, Medium Sized Clinical Chemistry, & Small Sized Clinical Chemistry), and Reagents (Metabolite Chemistry Reagents, Enzyme Chemistry Reagents, Electrolyte Chemistry Reagents, & Other Chemistry Reagents). The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Latin America. Annual forecasts are provided for each region for the period of 2000 through 2015. The report profiles 79 companies including many key and niche players worldwide such as Abbott Laboratories, Alfa Wassermann, Inc., Beckman Coulter, Inc., Cholestech Corporation, Hemagen Diagnostics, Inc., Ortho-Clinical Diagnostics, Olympus America, Roche Diagnostics, Siemens Healthcare Diagnostics, Inc., Sigma-Aldrich, and Sysmex Corporation. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.

Content

I. Introduction, Methodology & Product Definitions
- Study Reliability and Reporting Limitations
- Disclaimers
- Data Interpretation & Reporting Level
- Quantitative Techniques & Analytics
- Product Definitions and Scope of Study
- Clinical Chemistry Analyzers
- Large Volume Clinical Chemistry Analyzers
- Medium Sized Clinical Chemistry Analyzers
- Small Sized Clinical Chemistry Analyzers
- Reagents
- Metabolite Chemistry Reagents
- Enzyme Chemistry Reagents
- Electrolyte Chemistry Reagents
II. Executive Summary
- 1. Market Overview I
  - A Quick Primer I
  - Analyzers and Sensors Transform Clinical Diagnostics I
  - Clinical Laboratory Automation-Order of the Day I
  - Mass Spectrometry - A New Dimension in Clinical Diagnostics I
  - Nanotechnology Shapes the Future of Clinical Labs I
  - Northward Bound of Point-of-Care Testing I
  - Integrated Systems Cannibalize Single Unit Sales I
- 2. Diagnostic Industry Overview I
  - Exhibiting Rapid Change I
  - IVD Industry - An Overview I
  - Chemical Analysis - An Overview I
  - Human Anatomy is Chemistry Driven I
  - History of Chemical Analysis I
  - Chemical Tests to Determine the Concentration of Substances I
- 3. Product Overview I
  - Analyzers I
  - What are Clinical Chemistry Analyzers? I
  - Large Volume Clinical Chemistry Analyzers I
  - Medium Sized Clinical Chemistry Analyzers I
  - Small Sized Clinical Chemistry Analyzers I
  - Automated Analytical Methods I
  - Automated Analyzers I
  - Continuous Flow Analysis I
  - Discrete Analysis I
  - Test Tube Analyzers: Perennial Symbol of the Chemical Laboratory I
  - Advantages and Disadvantages of Test Tube Analyzers II-1
  - Reagents II-1
  - Different Applications of Reagents II-1
  - Metabolite Chemistry Reagents II-1
  - Enzyme Chemistry Reagents II-1
  - Electrolyte Chemistry Reagents II-1
- 4. Role of Computers in Clinical Chemistry II-1
  - Clinical Data Interpretation Supported by Computerization II-1
  - Bar Coding used to Increase Accuracy and Productivity II-1
  - Sample and Data Collection Process II-1
  - Modes in Clinical Chemistry for Sample Processing II-1
  - Batch Processing Mode: Test Oriented II-1
  - Random-access Processing Mode: Patient Oriented II-1
- 5. Clinical Laboratory Testing Services II-1
  - Hospital Testing Services II-1
  - Commercial Laboratories II-1
  - Physician's Office Laboratories II-1
- 6. Product Introductions II-1
  - Siemens Introduces DCA Vantage Analyzer for Diabetes Management II-1
  - Siemens Healthcare Introduces Folate, B12, and Ferritin Tests II-1
  - Beckman Coulter Launches Amylase EPS-G7 Assay II-1
  - Olympus Launches Automated AU680 Analyzer II-1
  - Agappe Unveils New Diagnostic Products in India II-1
  - Roche Diagnostics Extends HCV Immunoassay's Availability II-1
  - Abbott Laboratories Enhances Architect Analyzers II-1
  - Roche Diagnostics to Unveil New Products in Japan II-1
  - Applied Biosystems Expands Labeling Chemistry Reagents Line II-1
  - Olympus Unveils New Thyroid Panel for Immunoassay System II-1
  - Miraculins to Develop Clinical Immunoassays II-1
  - Olympus Offers Ready-for-Use Reagents for the PK7200 II-1
  - Beckman Coulter Unveils UniCel DxI 600 II-1
  - Olympus Launches D-Dimer Reagent II-1
  - Olympus Launches AU680 Chemistry-Immuno Analyzer II-1
  - Ortho-Clinical Launches Improved Sensitivity Troponin I Assay II-1
  - Siemens Healthcare Launches Version 2.0 Software II-1
  - Abaxis Introduces Unique 5-part Differential Veterinary Hematology Analyzer II-1
  - Roche Diagnostics Launches Clinical Chemistry Analyzer II-1
  - Siemens Healthcare Diagnostics Offers ADVIA 1800 Worldwide II-2
  - Siemens Adds Clinitek Advantus to Clinitek Urine Analyzers Product Line II-2
  - IDEXX Laboratories Introduces Diagnostic Health Profile II-2
  - Heska Corporation Unveils Dri Chem 4000 Chemistry Analyzer II-2
  - Sysmex Introduces HISCL-2000i II-2
  - Sysmex Introduces Automated Hematology Analyzer XE-5000 in Europe II-2
  - Siemens Healthcare Introduces DCA Vantage Analyzer II-2
  - Idexx Launches QC Panel for VetTest Chemistry Analyzer II-2
  - IRIS International Launches Urine Chemistry Analyzer II-2
  - Sysmex Launches Automated Hematology Analyzer II-2
  - Dade Behring Introduces Tacrolimus Test for Analyzers II-2
  - Sysmex to Introduce Automated Clinical Chemistry Analyzer in Asia II-2
  - Toshiba Launches Automated Clinical Chemistry Analyzer II-2
  - Ortho-Clinical Diagnostics Unveils New Micro Tip Assay II-2
  - Bayer HealthCare Expands Chemistry Testing Portfolio II-2
  - Olympus Showcases AU400 Chemistry Analyzer II-2
  - Dade Behring Develops Dimension VISTA II-2
  - Bayer Rolls out IMS Analyzer II-2
  - Bayer Introduces Urinalysis System II-2
  - Bayer HealthCare Introduces ADVIA WorkCellTM CDX II-2
  - Bayer Rolls out ADVIA 1200 Analyzer II-2
  - Ortho Diagnostics Launches VITROS 350 Chemistry System II-2
  - Beckman Expands UniCel Instruments Portfolio II-2
  - Polymedco Launches SPOTCHEM EZ- Chemistry Analyzer II-2
  - Ortho-Clinical Extends Testing Capabilities for the VITROS Chemistry System II-2
  - Abbott Unveils Cancer Tests for ARCHITECT Analyzers II-2
  - Abbott Rolls out 10 Clinical Chemistry Tests II-2
  - Abbott Laboratories Unveil New Assays for Therapeutic Drug Monitoring Management II-2
  - Roche Diagnostics Rolls out OMNI S 1-4 Models II-2
  - Roche Diagnostics Launches Urine Test Strip Analyzer II-2
  - Applied Biosystems Unveils BloodPrep Chemistry II-2
- 7. Recent Industry Activity II-2
  - Hologic to Take over Third Wave II-2
  - Miltenyi Announces Acquisition of Medic Tools II-2
  - Drew Scientific Acquires JAS II-2
  - Olympus Receives FDA Approval for PK Blood Grouping Reagents II-2
  - Ortho-Clinical Secures FDA Clearance for Latest HIV Test II-2
  - Bracco Acquires E-Z-EM II-2
  - Corgenix Inks Product Development and Distribution Agreement with Randox II-2
  - Quest Diagnostics Signs Long-term Agreement with Roche II-2
  - Novation Renews Agreement with Olympus to Purchase Chemistry Systems II-2
  - Sysmex Enters into Joint Venture Agreement with bioMrieux II-2
  - Third Wave Expands Core Intellectual Property Portfolio II-2
  - Olympus to Provide Middleware Solutions for Clinical Laboratories II-2
  - Fangyuan Pharmaceutical, IMDi Agree on Sino-Russian Biological Diagnosis Reagents Project II-3
  - Siemens Acquires Dade Behring II-3
  - Cliniqa Acquires Assets of Reagents Applications II-3
  - Cliniqa Acquires Assets of King Diagnostics and Compass Bioscience II-3
  - Genzyme to Take over Diagnostic Chemicals' Diagnostic Division II-3
  - Clinical Data Divests Vital Scientific for US$19.5 million II-3
  - DiaSys Takes over French Pols II-3
  - Siemens Healthcare Extends Distribution Accord with Sysmex II-3
  - Abaxis Signs Distribution Accord with McKesson II-3
  - Alfa Signs Distribution Accord with Hitachi II-3
  - Iris Signs Multi year Sales and Service Supply Accord with Amerinet II-3
  - Clinical Data Signs Accord with Sclavo Diagnostics International II-3
  - Premier Provides Roche HIV-1 Test Access to Members II-3
  - Roche Diagnostics Inks Contracts with Novation II-3
  - MedAssets Inks Contract with Siemens Healthcare II-3
  - Siemens Healthcare Diagnostics Inks Agreement with Amerinet II-3
  - Premier Selects Siemens Healthcare to Offer Integrated Urinalysis Solutions II-3
  - Roche Acquires BioVeris II-3
  - Sigma-Aldrich and Sangamo BioSciences Enter into Global Alliance II-3
  - Sysmex Establishes Sysmex Canada II-3
  - Sysmex Inks an Agreement with bioMerieux for Urinary Screening II-3
  - Inverness Acquires Cholestech II-3
  - Bio-Rad Inks Marketing Agreement with Siemens Healthcare II-3
  - Roche Receives FDA Approval for HIV-1 Test II-3
  - Roche Diagnostics and Sysmex Extend Distribution Agreement II-3
  - Sysmex Sign R&D and Clinical Development Agreements with Affymetrix II-3
  - Abaxis and HSIC Enter into Distribution Agreement II-3
  - Siemens Acquires Diagnostic Products II-3
  - Bayer Diagnostics and DPC Merged to Form Siemens Healthcare Diagnostics II-3
  - Olympus Enters into Distribution Agreement with PSS World Medical II-3
  - FDA Grants 510(k) Clearance for iChem 100 II-3
  - FDA Clears cobas 6000 Analyzer Range II-3
  - Sysmex Signs an Agreement with Roche Diagnostics II-3
  - Olympus Expands Immunoessay R&D Center II-3
  - NSAID Panel to Support VetTest Chemistry Analyzer II-3
  - Thermo and DP Enter into an Agreement for Clinical Chemistry Platform II-3
  - Clinical Data Inks Master Distribution Agreement with Daiichi Pure Chemicals II-3
  - Ortho-Clinical Diagnostics Receives FDA Clearance for Lipoprotein Assay II-3
  - IRIS Renews Agreement with ARKRAY II-3
  - Abbott Extends Assays to Diagnostic Laboratories II-3
  - Hemagen Receives FDA Stamp of Approval for Liquid Stable Reagents II-3
  - Abbott and Seradyn Obtain FDA Clearance for Hemoglobin Test for Diabetes II-3
  - Beckman Receives Approval for New Clinical Chemistry Analyzers II-4
  - Abbott Acquires I-Stat II-4
  - Hemagen Diagnostics Extends Supply Agreement with Roche II-4
  - Vital Scientific Bags FDA Clearance for V-Twin and Selectra XL II-4
  - Sysmex Bags Approval for Manufacturing Item 23 Clinical Chemistry Reagents II-4
  - Sysmex Initiates Marketing of RANREAM HCV II EX Reagent in Japan II-4
  - Invitrogen Bags Products and Technology Rights from Vertex II-4
  - diaDexus to Supply Analyte Specific Reagents to Mayo II-4
- 8. Focus on Select Global Players II-4
  - Abbott Laboratories (US) II-4
  - Alfa Wassermann, Inc.(US) II-4
  - Beckman Coulter, Inc.(US) II-4
  - Cholestech Corporation (US) II-4
  - Hemagen Diagnostics, Inc.(US) II-4
  - Ortho-Clinical Diagnostics (US) II-4
  - Olympus America (US) II-4
  - Roche Diagnostics (US) II-4
  - Siemens Healthcare Diagnostics, Inc (US) II-4
  - Sigma-Aldrich (US) II-4
  - Sysmex Corporation (Japan) II-4
- 9. Global Market Perspective II-4
III. Market
- 1. The United States II
  - A. Market Analysis II
    - Current and Future Analysis II
    - Ageing Population Creates More Opportunities II
    - Trends in the Clinical Chemistry Analyzers Market II
    - Reagent Rental Contracts Offer Viable Solution for Cost-Cuttings II
    - US Clinical Laboratory Analyzer Market II
    - CLIA- Regulatory Framework of Diagnostic Testing II
    - Product Introductions/Launches II
    - Strategic Corporate Developments III-1
    - Focus on Select US Players III-2
  - B. Market Analytics III-3
- 2. Canada III-3
  - A. Market Analysis III-3
    - Current and Future Analysis III-3
    - An Overview of the Medical Equipment Market III-3
    - Strategic Corporate Developments III-3
    - Focus on Key Canadian Player III-3
  - B. Market Analytics III-3
- 3. Japan III-3
  - A. Market Analysis III-3
    - Current and Future Analysis III-3
    - Strategic Corporate Developments III-3
    - Product Introductions/Launches III-3
    - Focus on Key Japanese Player III-3
  - B. Market Analytics III-4
- 4. Europe III-4
  - A. Market Analysis III-4
    - Current and Future Analysis III-4
    - European Immunochemistry Analyzers Market: An Overview III-4
    - Western Europe III-4
    - New Technologies Drive in Vitro Diagnostics Market Growth III-4
    - Product Launches III-4
  - B. Market Analytics III-4
- 4a. France III-5
  - A. Market Analysis III-5
    - Current and Future Analysis III-5
    - Clinical Chemistry Market in France III-5
    - French Laboratory Equipment Market III-5
    - Strategic Corporate Developments III-5
  - B. Market Analytics III-5
- 4b. Germany III-5
  - A. Market Analysis III-5
    - Current and Future Analysis III-5
    - Strategic Corporate Developments III-5
  - B. Market Analytics III-5
- 4c. Italy III-6
  - A. Market Analytics III-6
    - Current and Future Analysis III-6
    - Italian Laboratory Instruments Market III-6
  - B. Market Analytics III-6
- 4d. The United Kingdom III-6
  - A. Market Analysis III-6
    - Current and Future Analysis III-6
    - UK Instrumentation Market III-6
    - Strategic Corporate Development III-6
  - B. Market Analytics III-6
- 4e. Rest of Europe III-6
  - A. Market Analytics III-6
    - Current and Future Analysis III-6
    - Study of IVD Market in Spain III-6
    - Turkey III-6
    - Strategic Corporate Developments III-7
  - B. Market Analytics III-7
- 5. Asia-Pacific III-7
  - A. Market Analytics III-7
    - Current and Future Analysis III-7
    - Health-Care Industry in Asia-Pacific III-7
    - Key Asia-Pacific Markets III-7
    - China III-7
    - Australia III-7
    - Korea III-7
    - Clinical Chemistry Analyzers III-7
    - Clinical Laboratory Products III-7
    - Indonesia III-7
    - Singapore III-7
    - Taiwan III-7
    - Strategic Corporate Development III-7
    - Product Launches III-7
  - B. Market Analytics III-7
- 6. Latin America III-8
  - A. Market Analytics III-8
    - Current and Future Analysis III-8
    - Mexico III-8
  - B. Market Analytics III-8
IV. Competitive Landscape
List of Tables
- Table 1: in Vitro-Diagnostic Market Worldwide (2004): Percentage Share Breakdown of Revenues Generated by Segment (includes corresponding Graph/Chart) I
- Table 2: Leading Players in the Global IVD Market (2004): Percentage Share Breakdown by Value sales for Roche Diagnostics, Abbott, J&J/Ortho Clinical Diagnostics, Bayer, Beckman Coulter, and Others (includes corresponding Graph/Chart) I
- Table 3: Leading Players in the Global Clinical Chemistry Testing Market for 2001 & 2005: Market Share by Value Sales for Roche, Beckman Coulter, Dade Behring, Bayer, Ortho-Clinical Diagnostics, Abbott, and Others (includes corresponding Graph/Chart) I
- Table 4: Most Commonly Used Blood Tests I
- Table 5: World Recent past, Current & Future Analysis for Clinical Chemistry Analyzers and Reagents by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Latin American Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart) II-4
- Table 6: World Long-term Projections for Clinical Chemistry Analyzers and Reagents by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Latin American Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart) II-4
- Table 7: World 10-Year Perspective for Clinical Chemistry Analyzers and Reagents by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Latin American Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart) II-4
- Table 8: World Recent past, Current & Future Analysis for Analyzers by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Latin American Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart) II-5
- Table 9: World Long-term Projections for Analyzers by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Latin American Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart) II-5
- Table 10: World 10-Year Perspective for Analyzers by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Latin American Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart) II-5
- Table 11: World Recent past, Current & Future Analysis for Analyzers by Product Segment - Large Volume Clinical Chemistry Analyzers, Medium Sized Clinical Chemistry Analyzers and Small Sized Clinical Chemistry Analyzers Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart) II-5
- Table 12: World Long-term Projections for Analyzers by Product Segment - Large Volume Clinical Chemistry Analyzers, Medium Sized Clinical Chemistry Analyzers and Small Sized Clinical Chemistry Analyzers Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart) II-5
- Table 13: World 10-Year Perspective for Analyzers by Product Segment - Percentage Breakdown of Dollar Sales for Large Volume Clinical Chemistry Analyzers, Medium Sized Clinical Chemistry Analyzers and Small Sized Clinical Chemistry Analyzers Markets for 2003, 2008 & 2012 (includes corresponding Graph/Chart) II-5
- Table 14: World Recent past, Current & Future Analysis for Large Volume Clinical Chemistry Analyzers by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Latin American Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart) II-5
- Table 15: World Long-term Projections for Large Volume Clinical Chemistry Analyzers by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), and Latin American Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart) II-5
- Table 16: World 10-Year Perspective for Large Volume Clinical Chemistry Analyzers by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Latin American Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart) II-5
- Table 17: World Recent past, Current & Future Analysis for Medium Sized Clinical Chemistry Analyzers by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Latin American Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart) II-5
- Table 18: World Long-term Projections for Medium Sized Clinical Chemistry Analyzers by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Latin American Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart) II-6
- Table 19: World 10-Year Perspective for Medium Sized Clinical Chemistry Analyzers by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Latin American Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart) II-6
- Table 20: World Recent past, Current & Future Analysis for Small Sized Clinical Chemistry Analyzers by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Latin American Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart) II-6
- Table 21: World Long-term Projections for Small Sized Clinical Chemistry Analyzers by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), and Latin American Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart) II-6
- Table 22: World 10-Year Perspective for Small Sized Clinical Chemistry Analyzers by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Latin American Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart) II-6
- Table 23: World Recent past, Current & Future Analysis for Reagents by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Latin American Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart) II-6
- Table 24: World Long-term Projections for Reagents by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), and Latin American Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart) II-6
- Table 25: World 10-Year Perspective for Reagents by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Latin American Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart) II-6
- Table 26: World Recent past, Current & Future Analysis for Reagents by Product Segment- Metabolite Chemistry Reagents, Enzyme Chemistry Reagents, Electrolyte Chemistry Reagents, and Other Chemistry Reagents Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart) II-6
- Table 27: World Long-term Projections for Reagents by Product Segment- Metabolite Chemistry Reagents, Enzyme Chemistry Reagents, Electrolyte Chemistry Reagents, and Other Chemistry Reagents Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart) II-6
- Table 28: World 10-Year Perspective for Reagents by Product Segment - Percentage Breakdown of Dollar Sales for Metabolite Chemistry Reagents, Enzyme Chemistry Reagents, Electrolyte Chemistry Reagents, & Other Chemistry Reagents Markets for 2003, 2008 & 2012 (includes corresponding Graph/Chart) II-7
- Table 29: World Recent past, Current & Future Analysis for Metabolite Chemistry Reagents by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Latin American Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart) II-7
- Table 30: World Long-term Projections for Metabolite Chemistry Reagents by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), and Latin American Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart) II-7
- Table 31: World 10-Year Perspective for Metabolite Chemistry Reagents by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Latin American Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart) II-7
- Table 32: World Recent past, Current & Future Analysis for Enzyme Chemistry Reagents by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Latin American Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart) II-7
- Table 33: World Long-term Projections for Enzyme Chemistry Reagents by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), and Latin American Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart) II-7
- Table 34: World 10-Year Perspective for Enzyme Chemistry Reagents by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Latin American Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart) II-7
- Table 35: World Recent past, Current & Future Analysis for Electrolyte Chemistry Reagents by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Latin American Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart) II-7
- Table 36: World Long-term Projections for Electrolyte Chemistry Reagents by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), and Latin American Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart) II-7
- Table 37: World 10-Year Perspective for Electrolyte Chemistry Reagents by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Latin American Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart) II-7
- Table 38: World Recent past, Current & Future Analysis for Other Chemistry Reagents by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Latin American Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart) II-8
- Table 39: World Long-term Projections for Other Chemistry Reagents by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), and Latin American Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart) II-8
- Table 40: World 10-Year Perspective for Other Chemistry Reagents by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Latin American Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart) II-8
- Table 41: Leading Players in the US Clinical Chemistry Analyzers Market (2003-2005): Percentage Share Breakdown by Value Sales (*) for Beckman Coulter, Roche, Olympus, Ortho Clinical Diagnostics, Dade Behring, Bayer, Abbott, and Others (includes corresponding Graph/Chart) II
- Table 42: Leading Players in the US Clinical Chemistry Reagents Market (2003-2005): Percentage Share Breakdown by Value Sales (*) for Beckman Coulter, Roche, Ortho Clinical Diagnostics, Dade Behring, and Others (includes corresponding Graph/Chart) II
- Table 43: US Recent past, Current & Future Analysis for Clinical Chemistry Analyzers and Reagents by Product Segment- Analyzers (Large Volume Clinical Chemistry, Medium Sized Clinical Chemistry, and Small Sized Clinical Chemistry), and Reagents (Metabolite Chemistry Reagents, Enzyme Chemistry Reagents, Electrolyte Chemistry Reagents, and Other Chemistry Reagents) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart) III-3
- Table 44: US Long-term Projections for Clinical Chemistry Analyzers and Reagents by Product Segment- Analyzers (Large Volume Clinical Chemistry, Medium Sized Clinical Chemistry, and Small Sized Clinical Chemistry), and Reagents (Metabolite Chemistry Reagents, Enzyme Chemistry Reagents, Electrolyte Chemistry Reagents, and Other Chemistry Reagents) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart) III-3
- Table 45: US 10-Year Perspective for Clinical Chemistry Analyzers and Reagents by Product Segment - Percentage Breakdown of Dollar Sales for Analyzers (Large Volume Clinical Chemistry, Medium Sized Clinical Chemistry, and Small Sized Clinical Chemistry), and Reagents (Metabolite Chemistry Reagents, Enzyme Chemistry Reagents, Electrolyte Chemistry Reagents, and Other Chemistry Reagents) Markets for 2003, 2008 & 2012 (includes corresponding Graph/Chart) III-3
- Table 46: Canadian Recent past, Current & Future Analysis for Clinical Chemistry Analyzers and Reagents by Product Segment- Analyzers (Large Volume Clinical Chemistry, Medium Sized Clinical Chemistry, and Small Sized Clinical Chemistry), and Reagents (Metabolite Chemistry Reagents, Enzyme Chemistry Reagents, Electrolyte Chemistry Reagents, and Other Chemistry Reagents) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart) III-3
- Table 47: Canadian Long-term Projections for Clinical Chemistry Analyzers and Reagents by Product Segment- Analyzers (Large Volume Clinical Chemistry, Medium Sized Clinical Chemistry, and Small Sized Clinical Chemistry), and Reagents (Metabolite Chemistry Reagents, Enzyme Chemistry Reagents, Electrolyte Chemistry Reagents, and Other Chemistry Reagents) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart) III-3
- Table 48: Canadian 10-Year Perspective for Clinical Chemistry Analyzers and Reagents by Product Segment - Percentage Breakdown of Dollar Sales for Analyzers (Large Volume Clinical Chemistry, Medium Sized Clinical Chemistry, and Small Sized Clinical Chemistry), and Reagents (Metabolite Chemistry Reagents, Enzyme Chemistry Reagents, Electrolyte Chemistry Reagents, and Other Chemistry Reagents) Markets for 2003, 2008 & 2012 (includes corresponding Graph/Chart) III-3
- Table 49: Japanese Recent past, Current & Future Analysis for Clinical Chemistry Analyzers and Reagents by Product Segment- Analyzers (Large Volume Clinical Chemistry, Medium Sized Clinical Chemistry, and Small Sized Clinical Chemistry), and Reagents (Metabolite Chemistry Reagents, Enzyme Chemistry Reagents, Electrolyte Chemistry Reagents, and Other Chemistry Reagents) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart) III-4
- Table 50: Japanese Long-term Projections for Clinical Chemistry Analyzers and Reagents by Product Segment- Analyzers (Large Volume Clinical Chemistry, Medium Sized Clinical Chemistry, and Small Sized Clinical Chemistry), and Reagents (Metabolite Chemistry Reagents, Enzyme Chemistry Reagents, Electrolyte Chemistry Reagents, and Other Chemistry Reagents) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart) III-4
- Table 51: Japanese 10-Year Perspective for Clinical Chemistry Analyzers and Reagents by Product Segment - Percentage Breakdown of Dollar Sales for Analyzers (Large Volume Clinical Chemistry, Medium Sized Clinical Chemistry, and Small Sized Clinical Chemistry), and Reagents (Metabolite Chemistry Reagents, Enzyme Chemistry Reagents, Electrolyte Chemistry Reagents, and Other Chemistry Reagents) Markets for 2003, 2008 & 2012(includes corresponding Graph/Chart) III-4
- Table 52: Leading Players in the European Immunochemistry Analysers Market (2007): Percentage Share Breakdown of Value Sales for Roche Diagnostics, Siemens Medical Solutions Diagnostics, Abbott Diagnostics, Beckman Coulter, Dade Behring, Ortho Clinical Diagnostics, and Others (includes corresponding Graph/Chart) III-4
- Table 53: European Recent past, Current & Future Analysis for Clinical Chemistry Analyzers and Reagents by Geographic Region- France, Germany, Italy, UK, and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart) III-4
- Table 54: European Long-term Projections for Clinical Chemistry Analyzers and Reagents by Geographic Region- France, Germany, Italy, UK, and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart) III-4
- Table 55: European 10-Year Perspective for Clinical Chemistry Analyzers and Reagents by Geographic Region- Percentage Breakdown of Dollar Sales for France, Germany, Italy, UK, and Rest of Europe Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart) III-4
- Table 56: European Recent past, Current & Future Analysis for Clinical Chemistry Analyzers and Reagents by Product Segment- Analyzers (Large Volume Clinical Chemistry, Medium Sized Clinical Chemistry, and Small Sized Clinical Chemistry), and Reagents (Metabolite Chemistry Reagents, Enzyme Chemistry Reagents, Electrolyte Chemistry Reagents, and Other Chemistry Reagents) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart) III-4
- Table 57: European Long-term Projections for Clinical Chemistry Analyzers and Reagents by Product Segment- Analyzers (Large Volume Clinical Chemistry, Medium Sized Clinical Chemistry, and Small Sized Clinical Chemistry), and Reagents (Metabolite Chemistry Reagents, Enzyme Chemistry Reagents, Electrolyte Chemistry Reagents, and Other Chemistry Reagents) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart) III-5
- Table 58: European 10-Year Perspective for Clinical Chemistry Analyzers and Reagents by Product Segment - Percentage Breakdown of Dollar Sales for Analyzers (Large Volume Clinical Chemistry, Medium Sized Clinical Chemistry, and Small Sized Clinical Chemistry), and Reagents (Metabolite Chemistry Reagents, Enzyme Chemistry Reagents, Electrolyte Chemistry Reagents, and Other Chemistry Reagents) Markets for 2003, 2008 & 2012 (includes corresponding Graph/Chart) III-5
- Table 59: French Recent past, Current & Future Analysis for Clinical Chemistry Analyzers and Reagents by Product Segment- Analyzers (Large Volume Clinical Chemistry, Medium Sized Clinical Chemistry, and Small Sized Clinical Chemistry), and Reagents (Metabolite Chemistry Reagents, Enzyme Chemistry Reagents, Electrolyte Chemistry Reagents, and Other Chemistry Reagents) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart) III-5
- Table 60: French Long-term Projections for Clinical Chemistry Analyzers and Reagents by Product Segment- Analyzers (Large Volume Clinical Chemistry, Medium Sized Clinical Chemistry, and Small Sized Clinical Chemistry), and Reagents (Metabolite Chemistry Reagents, Enzyme Chemistry Reagents, Electrolyte Chemistry Reagents, and Other Chemistry Reagents) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart) III-5
- Table 61: French 10-Year Perspective for Clinical Chemistry Analyzers and Reagents by Product Segment - Percentage Breakdown of Dollar Sales for Analyzers (Large Volume Clinical Chemistry, Medium Sized Clinical Chemistry, and Small Sized Clinical Chemistry), and Reagents (Metabolite Chemistry Reagents, Enzyme Chemistry Reagents, Electrolyte Chemistry Reagents, and Other Chemistry Reagents) Markets for 2003, 2008 & 2012 (includes corresponding Graph/Chart) III-5
- Table 62: German Recent past, Current & Future Analysis for Clinical Chemistry Analyzers and Reagents by Product Segment- Analyzers (Large Volume Clinical Chemistry, Medium Sized Clinical Chemistry, and Small Sized Clinical Chemistry), and Reagents (Metabolite Chemistry Reagents, Enzyme Chemistry Reagents, Electrolyte Chemistry Reagents, and Other Chemistry Reagents) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart) III-5
- Table 63: German Long-term Projections for Clinical Chemistry Analyzers and Reagents by Product Segment- Analyzers (Large Volume Clinical Chemistry, Medium Sized Clinical Chemistry, and Small Sized Clinical Chemistry), and Reagents (Metabolite Chemistry Reagents, Enzyme Chemistry Reagents, Electrolyte Chemistry Reagents, and Other Chemistry Reagents) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart) III-5
- Table 64: German 10-Year Perspective for Clinical Chemistry Analyzers and Reagents by Product Segment - Percentage Breakdown of Dollar Sales for Analyzers (Large Volume Clinical Chemistry, Medium Sized Clinical Chemistry, and Small Sized Clinical Chemistry), and Reagents (Metabolite Chemistry Reagents, Enzyme Chemistry Reagents, Electrolyte Chemistry Reagents, and Other Chemistry Reagents) Markets for 2003, 2008 & 2012 (includes corresponding Graph/Chart) III-6
- Table 65: Italian Recent past, Current & Future Analysis for Clinical Chemistry Analyzers and Reagents by Product Segment- Analyzers (Large Volume Clinical Chemistry, Medium Sized Clinical Chemistry, and Small Sized Clinical Chemistry), and Reagents (Metabolite Chemistry Reagents, Enzyme Chemistry Reagents, Electrolyte Chemistry Reagents, and Other Chemistry Reagents) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart) III-6
- Table 66: Italian Long-term Projections for Clinical Chemistry Analyzers and Reagents by Product Segment- Analyzers (Large Volume Clinical Chemistry, Medium Sized Clinical Chemistry, and Small Sized Clinical Chemistry), and Reagents (Metabolite Chemistry Reagents, Enzyme Chemistry Reagents, Electrolyte Chemistry Reagents, and Other Chemistry Reagents) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart) III-6
- Table 67: Italian 10-Year Perspective for Clinical Chemistry Analyzers and Reagents by Product Segment - Percentage Breakdown of Dollar Sales for Analyzers (Large Volume Clinical Chemistry, Medium Sized Clinical Chemistry, and Small Sized Clinical Chemistry), and Reagents (Metabolite Chemistry Reagents, Enzyme Chemistry Reagents, Electrolyte Chemistry Reagents, and Other Chemistry Reagents) Markets for 2003, 2008 & 2012 (includes corresponding Graph/Chart) III-6
- Table 68: UK Recent past, Current & Future Analysis for Clinical Chemistry Analyzers and Reagents by Product Segment- Analyzers (Large Volume Clinical Chemistry, Medium Sized Clinical Chemistry, and Small Sized Clinical Chemistry), and Reagents (Metabolite Chemistry Reagents, Enzyme Chemistry Reagents, Electrolyte Chemistry Reagents, and Other Chemistry Reagents) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart) III-6
- Table 69: UK Long-term Projections for Clinical Chemistry Analyzers and Reagents by Product Segment- Analyzers (Large Volume Clinical Chemistry, Medium Sized Clinical Chemistry, and Small Sized Clinical Chemistry), and Reagents (Metabolite Chemistry Reagents, Enzyme Chemistry Reagents, Electrolyte Chemistry Reagents, and Other Chemistry Reagents) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart) III-6
- Table 70: UK 10-Year Perspective for Clinical Chemistry Analyzers and Reagents by Product Segment - Percentage Breakdown of Dollar Sales for Analyzers (Large Volume Clinical Chemistry, Medium Sized Clinical Chemistry, and Small Sized Clinical Chemistry), and Reagents (Metabolite Chemistry Reagents, Enzyme Chemistry Reagents, Electrolyte Chemistry Reagents, and Other Chemistry Reagents) Markets for 2003, 2008 & 2012 (includes corresponding Graph/Chart) III-6
- Table 71: Rest of Europe Recent past, Current & Future Analysis for Clinical Chemistry Analyzers and Reagents by Product Segment- Analyzers (Large Volume Clinical Chemistry, Medium Sized Clinical Chemistry, and Small Sized Clinical Chemistry), and Reagents (Metabolite Chemistry Reagents, Enzyme Chemistry Reagents, Electrolyte Chemistry Reagents, and Other Chemistry Reagents) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart) III-7
- Table 72: Rest of Europe Long-term Projections for Clinical Chemistry Analyzers and Reagents by Product Segment- Analyzers (Large Volume Clinical Chemistry, Medium Sized Clinical Chemistry, and Small Sized Clinical Chemistry), and Reagents (Metabolite Chemistry Reagents, Enzyme Chemistry Reagents, Electrolyte Chemistry Reagents, and Other Chemistry Reagents) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart) III-7
- Table 73: Rest of Europe 10-Year Perspective for Clinical Chemistry Analyzers and Reagents by Product Segment - Percentage Breakdown of Dollar Sales for Analyzers (Large Volume Clinical Chemistry, Medium Sized Clinical Chemistry, and Small Sized Clinical Chemistry), and Reagents (Metabolite Chemistry Reagents, Enzyme Chemistry Reagents, Electrolyte Chemistry Reagents, and Other Chemistry Reagents) Markets for 2003, 2008 & 2012 (includes corresponding Graph/Chart) III-7
- Table 74: Clinical Laboratory Instrumentation Market in South Korea (2006): Percentage Share Breakdown of Value Sales by Segment (includes corresponding Graph/Chart) III-7
- Table 75: Asia-Pacific Recent past, Current & Future Analysis for Clinical Chemistry Analyzers and Reagents by Product Segment- Analyzers (Large Volume Clinical Chemistry, Medium Sized Clinical Chemistry, and Small Sized Clinical Chemistry), and Reagents (Metabolite Chemistry Reagents, Enzyme Chemistry Reagents, Electrolyte Chemistry Reagents, and Other Chemistry Reagents) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart) III-7
- Table 76: Asia-Pacific Long-term Projections for Clinical Chemistry Analyzers and Reagents by Product Segment- Analyzers (Large Volume Clinical Chemistry, Medium Sized Clinical Chemistry, and Small Sized Clinical Chemistry), and Reagents (Metabolite Chemistry Reagents, Enzyme Chemistry Reagents, Electrolyte Chemistry Reagents, and Other Chemistry Reagents) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart) III-7
- Table 77: Asia-Pacific 10-Year Perspective for Clinical Chemistry Analyzers and Reagents by Product Segment - Percentage Breakdown of Dollar Sales for Analyzers (Large Volume Clinical Chemistry, Medium Sized Clinical Chemistry, and Small Sized Clinical Chemistry), and Reagents (Metabolite Chemistry Reagents, Enzyme Chemistry Reagents, Electrolyte Chemistry Reagents, and Other Chemistry Reagents) Markets for 2003, 2008 & 2012 (includes corresponding Graph/Chart) III-8
- Table 78: Latin America Recent past, Current & Future Analysis for Clinical Chemistry Analyzers and Reagents by Product Segment- Analyzers (Large Volume Clinical Chemistry, Medium Sized Clinical Chemistry, and Small Sized Clinical Chemistry), and Reagents (Metabolite Chemistry Reagents, Enzyme Chemistry Reagents, Electrolyte Chemistry Reagents, and Other Chemistry Reagents) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart) III-8
- Table 79: Latin America Long-term Projections for Clinical Chemistry Analyzers and Reagents by Product Segment- Analyzers (Large Volume Clinical Chemistry, Medium Sized Clinical Chemistry, and Small Sized Clinical Chemistry), and Reagents (Metabolite Chemistry Reagents, Enzyme Chemistry Reagents, Electrolyte Chemistry Reagents, and Other Chemistry Reagents) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart) III-8
- Table 80: Latin America 10-Year Perspective for Clinical Chemistry Analyzers and Reagents by Product Segment - Percentage Breakdown of Dollar Sales for Analyzers (Large Volume Clinical Chemistry, Medium Sized Clinical Chemistry, and Small Sized Clinical Chemistry), and Reagents (Metabolite Chemistry Reagents, Enzyme Chemistry Reagents, Electrolyte Chemistry Reagents, and Other Chemistry Reagents) Markets for 2003, 2008 & 2012 (includes corresponding Graph/Chart) III-8